AOD 9604 peptide, also called the fat-burning peptide, is an anti-obesity drug (AOD) that can also be used for losing weight for non-obese patients
Dev Neurobiol
Indeed, many of the traditional CVD risk factors, including oxidized low-density lipoprotein[313], hyperlipidemia (hypercholesterolemia or mixed dyslipidemia)[314] insulin resistance[309, 310, 312], diabetes[315], obesity[309, 311], elevated C-reactive protein[316], waist-to-hip ratio[309], reduced coronary flow reserve[279], smoking[317], sedentary life[318] and psychological distress[319], which act via effects on endothelial dysfunction, apoptosis and impaired endothelial-dependent vascular reactivity, have been associated with low serum IGF-I levels and reduced IGF-I and IGF-IR mRNA as well as protein expression in vascular smooth muscle cells (VSMC)[313]
Because of this, it is often included in research focused on wound healing, recovery support, and tissue regeneration
If your levels don't improve upon supplementation, investigate underlying GI conditions and medication interactions that could impair absorption
